2m 2m 2m 2m 2m 2m 2m
AdaptHealth (AHCO)
NASDAQ
$9.74+$0.09 (+0.93%)
Price as of Jun 03, 2026 4:23 PM EDT- $1.4BMarket Cap
- 8.92%1-Year Change
- Medical DevicesIndustry
AdaptHealth (AHCO)
$9.74+$0.09 (+0.93%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 3.2B -0.49% | 3.3B +1.90% | 3.2B +7.73% | 3.0B +21.02% | |
Cost of Revenue | 2.6B +2.16% | 2.6B -5.17% | 2.7B +6.56% | 2.6B +27.09% | |
Gross Profit | 609.2M -10.56% | 681.1M +42.02% | 479.6M +14.89% | 417.4M -6.32% | |
Sales and Marketing Expense | 21.5M -4.44% | 22.5M -1.32% | 22.8M +18.75% | 19.2M +3.78% | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 381.9M +4.54% | 365.3M -4.56% | 382.8M +9.00% | 351.2M +655.22% | |
Total Operating Expenses | 3.2B +6.32% | 3.0B -21.10% | 3.8B +36.63% | 2.8B +24.14% | |
Operating Profit | 90.9M -65.54% | 263.7M +144.07% | -598.4M -414.27% | 190.4M -15.60% | |
Interest Income | N/A N/A | N/A N/A | 1.9M 0.00% | 1.9M 0.00% | |
Interest Expense | -105.8M -16.51% | -126.7M -2.79% | -130.3M +19.09% | -109.4M +14.94% | |
Interest Income and Expense and Net | -105.8M -16.51% | -126.7M -1.35% | -128.4M +19.43% | -107.5M +15.24% | |
Total Nonoperating Income and Expense | -274,000 -90.19% | -2.8M -90.55% | -29.6M +11,586.17% | -253,000 -86.19% | |
Income before Taxes | -15.2M -111.14% | 136.0M +118.79% | -723.8M -839.29% | 97.9M -48.73% | |
Income Taxes | 50.9M +23.39% | 41.2M +184.15% | -49.0M -297.84% | 24.8M -24.50% | |
Extraordinary Items | 1.2M -55.56% | 2.7M N/A | N/A N/A | N/A N/A | |
Net Income | -70.8M -178.29% | 90.4M +113.32% | -678.9M -1,079.42% | 69.3M -55.62% | |
Net Income from Continuing Operations Applicable to Common | -15.2M -111.14% | 136.0M +118.79% | -723.8M -839.29% | 97.9M -48.73% | |
Basic EPS and Net Income | -0.52 -183.87% | 0.62 +112.25% | -5.06 -1,176.60% | 0.47 -58.04% | |
Diluted EPS and Net Income | -0.52 -185.25% | 0.61 +111.49% | -5.31 -1,709.09% | 0.33 -50.75% | |
Basic Weighted Average Shares | 135.1M +1.04% | 133.8M -0.30% | 134.2M -0.01% | 134.2M +6.23% | |
Diluted Weighted Average Shares | 135.1M -0.28% | 135.5M +0.83% | 134.4M -3.29% | 139.0M +4.48% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 106.1M -3.29% | 109.7M +42.28% | 77.1M +66.69% | 46.3M -69.08% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 106.1M -3.29% | 109.7M +42.28% | 77.1M +66.69% | 46.3M -69.08% | |
Total Current Assets | 728.9M -3.56% | 755.8M +16.45% | 649.0M +10.89% | 585.3M -12.65% | |
Accumulated Depreciation | 524.1M +1.15% | 518.2M +18.58% | 437.0M +14.04% | 383.2M +72.92% | |
Property and Plant and Equipment and Net | 510.0M +7.46% | 474.6M -4.15% | 495.1M +1.65% | 487.1M +22.20% | |
Total Long-Term Assets | 19.1M +8.73% | 17.6M -16.77% | 21.1M -5.74% | 22.4M +48.46% | |
Total Assets | 4.3B -3.80% | 4.5B -0.48% | 4.5B -13.62% | 5.2B -0.59% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 20.3M +25.00% | 16.3M -69.55% | 53.4M +52.48% | 35.0M +75.00% | |
Total Current Liabilities | 712.4M +25.65% | 567.0M +5.58% | 537.0M +17.71% | 456.2M -8.72% | |
Total Long-Term Debt | 1.7B -12.67% | 2.0B -6.19% | 2.1B -2.72% | 2.2B -1.39% | |
Total Long-Term Liabilities | 243.8M -10.37% | 272.0M -9.96% | 302.1M -1.12% | 305.5M -5.27% | |
Total Liabilities | 2.8B -4.08% | 2.9B -4.38% | 3.0B -0.65% | 3.1B -3.83% | |
Retained Earnings | -633.0M +12.59% | -562.2M -13.86% | -652.6M -2,581.84% | 26.3M +161.12% | |
Total Stockholders Equity | 1.5B -3.35% | 1.6B +7.73% | 1.5B -32.20% | 2.2B +4.33% | |
Total Shares Outstanding | 135.5M +0.63% | 134.6M +1.48% | 132.6M -1.34% | 134.4M +0.44% | |
Cash Flow | |||||
Cash from Operating Activities | 601.8M +11.06% | 541.8M +12.73% | 480.7M +28.57% | 373.9M +35.62% | |
Capital Expenditures | 382.4M +24.94% | 306.1M -9.31% | 337.5M -13.79% | 391.4M +92.53% | |
Cash from Investing Activities | -303.2M -2.28% | -310.3M -13.16% | -357.3M -13.11% | -411.2M -77.47% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -302.2M +51.89% | -198.9M +115.01% | -92.5M +40.09% | -66.1M -104.13% | |
Financials Ratio | |||||
Gross Margin | 18.77% -10.11% | 20.89% +39.38% | 14.99% +6.64% | 14.05% -22.60% | |
Operating Margin | 2.80% -65.37% | 8.09% +143.25% | -18.70% -391.72% | 6.41% -30.26% | |
Return on Assets | -1.61% -180.00% | 2.01% +114.40% | -13.96% -1,154.09% | 1.32% -70.05% | |
Return on Equity | -4.58% -176.77% | 5.97% +115.87% | -37.62% -1,243.17% | 3.29% -74.54% | |
Revenue Growth | -0.49% -126.02% | 1.90% -75.42% | 7.73% -63.24% | 21.02% -84.11% | |
Current Ratio | 1.02 -23.24% | 1.33 +10.29% | 1.21 -5.80% | 1.28 -4.30% | |
Cash Ratio | 0.15 -23.04% | 0.19 +34.82% | 0.14 +41.62% | 0.10 -66.13% | |
Debt-to-Equity Ratio | 1.14 -9.33% | 1.26 -14.38% | 1.47 +44.78% | 1.02 -4.81% | |
Debt-to-Assets Ratio | 0.40 -8.90% | 0.44 -7.33% | 0.48 +13.65% | 0.42 -0.12% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow